Marvel Biosciences (TSXV:MRVL) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:MRVL Marvel Biosciences Corp TSXV:MRVL
34 GF Score
Price C$0.16
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSXV:MRVL
34GF Score
Marvel Biosciences Corp TSXV:MRVL
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Business Description

Other Exchanges MBCOF:USA
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for TSXV:MRVL

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.16
Price